MDT Medtronic plc. Ordinary Shares
Sobre Medtronic plc. Ordinary Shares Visão geral da empresa da Wikipedia
Medtronic é uma empresa de tecnologia médica de Minneapolis, Estados Unidos que foi fundada em 1949 por Earl Bakken e Palmer Hermundslie.
Ler mais
Medtronic é uma empresa de tecnologia médica de Minneapolis, Estados Unidos que foi fundada em 1949 por Earl Bakken e Palmer Hermundslie.
Está presente no mercado português desde 1998 e desde 2006 que é reconhecida como uma das melhores empresas para trabalhar.
== Referências ==
Fonte: Wikipedia, CC BY-SA 4.0 · Ver na Wikipedia ↗
MDT Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
MDT Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor |
|---|---|
| 26 de Junho de 2026 | $0,7200 |
| 27 de Março de 2026 | $0,7100 |
| 26 de Dezembro de 2025 | $0,7100 |
| 26 de Setembro de 2025 | $0,7100 |
| 27 de Junho de 2025 | $0,7100 |
| 28 de Março de 2025 | $0,7000 |
| 27 de Dezembro de 2024 | $0,7000 |
| 27 de Setembro de 2024 | $0,7000 |
| 28 de Junho de 2024 | $0,7000 |
| 21 de Março de 2024 | $0,6900 |
| 19 de Dezembro de 2023 | $0,6900 |
| 21 de Setembro de 2023 | $0,6900 |
| 22 de Junho de 2023 | $0,6900 |
| 23 de Março de 2023 | $0,6800 |
| 20 de Dezembro de 2022 | $0,6800 |
| 22 de Setembro de 2022 | $0,6800 |
| 23 de Junho de 2022 | $0,6800 |
| 24 de Março de 2022 | $0,6300 |
| 21 de Dezembro de 2021 | $0,6300 |
| 23 de Setembro de 2021 | $0,6300 |
MDT Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 10 29,4%
- Compra 12 35,3%
- Manter 12 35,3%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
25 analistas · 2026-08-22Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Dezembro de 2026 | $1.55 | $1.56 | — |
| 30 de Junho de 2026 | $1.55 | $1.56 | -0.01% |
| 31 de Março de 2026 | $1.36 | $1.35 | 0.01% |
| 31 de Dezembro de 2025 | $1.36 | $1.33 | 0.03% |
| 30 de Setembro de 2025 | $1.26 | $1.24 | 0.02% |
| 30 de Junho de 2025 | $1.62 | $1.59 | 0.03% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| MDT | $106.66B | 22.3 | 8.4% | 13.2% | 9.8% | — |
| STE | $21.63B | 27.9 | 8.7% | 13.2% | 11.3% | 44.2% |
| TRIB | — | — | — | — | — | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 15
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.36B | $33.54B | $32.36B | $31.23B | $31.69B | $30.12B | $28.91B | $30.56B | $29.95B | $29.71B | $28.83B | $20.26B | |
| Cost of Revenue | $12.72B | $11.63B | $11.22B | $10.72B | $10.14B | $10.48B | $9.42B | $9.15B | $9.07B | $9.29B | $9.14B | $6.31B | |
| Gross Profit | · | · | · | · | · | · | · | · | $20.90B | $20.42B | $19.69B | $13.95B | |
| SG&A Expense | $11.78B | $10.85B | $10.74B | $10.41B | $10.29B | $10.15B | $10.11B | $10.42B | $10.24B | $10.02B | $9.47B | $6.90B | |
| Operating Income | $6.47B | $5.96B | $5.14B | $5.49B | $5.75B | $4.48B | $4.79B | $6.27B | $6.64B | $5.38B | $5.36B | $3.77B | |
| Interest Expense | · | · | $719M | $636M | $553M | $925M | $1.09B | $1.44B | $1.15B | $1.09B | $1.39B | $666M | |
| Other Non-op | $384M | $402M | $412M | $515M | $318M | $336M | $356M | $373M | $181M | $313M | $-107M | $-118M | |
| Pretax Income | $6.14B | $5.63B | $4.84B | $5.36B | $5.52B | $3.90B | $4.05B | $5.20B | $5.67B | $4.60B | $4.34B | $3.49B | |
| Income Tax | $1.30B | $936M | $1.13B | $1.58B | $456M | $265M | $-751M | $547M | $2.58B | $578M | $798M | $811M | |
| Net Income | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B | $3.61B | $4.79B | $4.63B | $3.10B | $4.03B | $3.54B | $2.67B | |
| EPS (Basic) | $3.75 | $3.63 | $2.77 | $2.83 | $3.75 | $2.68 | $3.57 | $3.44 | $2.29 | $2.92 | $2.51 | $2.44 | |
| EPS (Diluted) | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 | $3.54 | $3.41 | $2.27 | $2.89 | $2.48 | $2.41 | |
| Shares (Basic) | 1,281,800,000 | 1,285,600,000 | 1,327,700,000 | 1,329,800,000 | 1,342,400,000 | 1,344,900,000 | 1,340,700,000 | 1,346,400,000 | 1,356,700,000 | 1,378,900,000 | 1,409,600,000 | 1,095,500,000 | |
| Shares (Diluted) | 1,288,100,000 | 1,289,900,000 | 1,330,200,000 | 1,332,800,000 | 1,351,400,000 | 1,354,000,000 | 1,351,100,000 | 1,357,500,000 | 1,368,200,000 | 1,391,400,000 | 1,425,900,000 | 1,109,000,000 | |
| EBITDA | $9.43B | $8.82B | $7.79B | $8.18B | $8.46B | $7.19B | $7.45B | $8.93B | $9.29B | $8.25B | $8.11B | $5.07B |
Balanço Patrimonial 30
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.95B | $2.22B | $1.28B | $1.54B | $3.71B | $3.59B | $4.14B | $4.39B | $3.67B | $4.97B | $2.88B | $4.84B | |
| Short-term Investments | $7.27B | $6.75B | $6.72B | $6.42B | $6.86B | $7.22B | $6.81B | $5.46B | $7.56B | $8.74B | $9.76B | $14.64B | |
| Receivables | $6.64B | $6.51B | $6.13B | $6.00B | $5.55B | $5.46B | $4.64B | $6.22B | $5.99B | $5.59B | $5.56B | $5.11B | |
| Inventory | $5.95B | $5.48B | $5.22B | $5.29B | $4.62B | $4.31B | $4.23B | $3.75B | $3.58B | $3.34B | $3.47B | $3.46B | |
| Prepaid Expense | · | · | · | · | · | · | · | · | · | $1.86B | $1.93B | $1.45B | |
| Other Current Assets | $2.97B | $2.86B | $2.58B | $2.42B | $2.32B | $1.96B | $2.21B | $2.14B | $2.19B | $1.86B | $1.93B | · | |
| Current Assets | $24.79B | $23.81B | $21.93B | $21.68B | $23.06B | $22.55B | $22.03B | $21.97B | $22.98B | $24.87B | $23.60B | $30.84B | |
| PP&E (Net) | $7.42B | $6.84B | $6.13B | $5.57B | $5.41B | $5.22B | $4.83B | $4.67B | $4.60B | $4.36B | $4.84B | $4.70B | |
| PP&E (Gross) | · | · | · | · | $13.37B | $12.70B | $11.64B | $10.92B | $10.26B | $9.69B | $9.71B | $8.86B | |
| Accum. Depreciation | · | · | · | · | $7.95B | $7.48B | $6.82B | $6.25B | $5.66B | $5.33B | $4.87B | $4.16B | |
| Goodwill | $42.59B | $41.74B | $40.99B | $41.42B | $40.50B | $41.96B | $39.84B | $39.96B | $39.54B | $38.52B | $41.50B | $40.53B | |
| Intangibles | $10.15B | $11.67B | $13.22B | $14.84B | $15.60B | $17.74B | $19.06B | $20.56B | $21.72B | $23.41B | $26.90B | $28.10B | |
| Other Non-current Assets | $4.15B | $3.58B | $4.05B | $3.96B | $3.01B | $2.44B | $2.09B | $1.01B | $1.08B | $1.23B | $1.42B | $1.74B | |
| Total Assets | $93.03B | $91.68B | $89.98B | $90.95B | $90.98B | $93.08B | $90.69B | $89.69B | $91.39B | $99.86B | $99.64B | $106.69B | |
| Accounts Payable | $2.64B | $2.45B | $2.41B | $2.66B | $2.28B | $2.11B | $2.00B | $1.95B | $1.63B | $1.55B | $1.71B | $1.61B | |
| Short-term Debt | · | $0 | $1.07B | $0 | · | · | · | · | · | · | · | · | |
| Current Liabilities | $11.66B | $12.88B | $10.79B | $9.05B | $12.39B | $8.51B | $10.37B | $8.47B | $10.08B | $14.26B | $7.17B | $9.17B | |
| Capital Leases | $989M | $918M | $840M | $869M | $703M | $829M | $774M | $10M | · | · | · | · | |
| Deferred Tax | $362M | $403M | $515M | $708M | $884M | $1.03B | $1.17B | $1.28B | $1.42B | $2.98B | $3.73B | $4.70B | |
| Other Non-current Liabilities | $2.06B | $1.77B | $1.36B | $1.73B | $1.41B | $1.76B | $1.66B | $757M | $889M | $1.51B | $1.92B | $1.82B | |
| Total Liabilities | $42.96B | $43.42B | $39.56B | $39.28B | $38.26B | $41.48B | $39.82B | $39.48B | $40.57B | $49.53B | $47.58B | $53.45B | |
| Long-term Debt | · | · | · | · | · | · | $24.92B | $25.39B | $25.75B | $33.37B | $30.94B | $35.59B | |
| Total Debt | · | $0 | $1.07B | · | · | · | $24.92B | $25.39B | $25.75B | $33.37B | $30.94B | $35.59B | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $20.93B | $20.83B | $23.13B | $24.59B | $24.57B | $26.32B | $26.16B | $26.53B | $28.13B | $29.55B | $32.23B | · | |
| Retained Earnings | $32.64B | $31.48B | $30.40B | $30.39B | $30.25B | $28.59B | $28.13B | $26.27B | $24.38B | $23.27B | $21.70B | $54.41B | |
| AOCI | $-4.10B | $-4.28B | $-3.32B | $-3.50B | $-2.27B | $-3.48B | $-3.56B | $-2.71B | $-1.79B | $-2.61B | $-1.87B | $-1.18B | |
| Stockholders' Equity | $49.46B | $48.02B | $50.21B | $51.48B | $52.55B | $51.43B | $50.74B | $50.09B | $50.72B | $50.21B | $52.06B | $53.23B | |
| Liabilities + Equity | $93.03B | $91.68B | $89.98B | $90.95B | $90.98B | $93.08B | $90.69B | $89.69B | $91.39B | $99.86B | $99.64B | $106.69B | |
| Shares Outstanding | 1,280,177,293 | 1,281,934,628 | 1,311,000,000 | 1,331,000,000 | 1,331,000,000 | 1,345,000,000 | 1,341,000,000 | 1,341,000,000 | 1,354,000,000 | 1,369,000,000 | 1,399,000,000 | 1,422,000,000 |
Fluxo de Caixa 20
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.96B | $2.86B | $2.65B | $2.70B | $2.71B | $2.70B | $2.66B | $2.66B | $2.64B | $2.92B | $2.82B | $1.31B | |
| Stock-based Comp | $457M | $429M | $393M | $355M | $359M | $344M | $297M | $290M | $344M | $348M | $375M | $439M | |
| Deferred Tax | $31M | $-339M | $-528M | $-253M | $-611M | $-461M | $-1.28B | $-438M | $-1.11B | $-876M | $-477M | $-819M | |
| Amort. of Intangibles | $1.77B | $1.81B | $1.69B | $1.70B | $1.73B | $1.78B | $1.76B | $1.76B | $1.82B | $1.98B | $1.90B | $733M | |
| Restructuring | · | · | $389M | $647M | $335M | $539M | $462M | · | · | · | · | · | |
| Other Non-cash | $-917M | $-569M | $599M | $-518M | $-148M | $49M | $762M | $-135M | $-293M | $463M | $-1.04B | $1.30B | |
| Operating Cash Flow | $7.33B | $7.04B | $6.79B | $6.04B | $7.35B | $6.24B | $7.23B | $7.01B | $4.68B | $6.88B | $5.22B | $4.90B | |
| CapEx | $1.90B | $1.86B | $1.59B | $1.46B | $1.37B | $1.35B | $1.21B | $1.13B | $1.07B | $1.25B | $1.05B | $571M | |
| Investing Cash Flow | $-2.93B | $-1.94B | $-2.37B | $-3.49B | $-1.66B | $-2.87B | $-3.20B | $-774M | $5.86B | $-1.57B | $2.25B | $-17.06B | |
| Debt Issued | $1.75B | $3.21B | $0 | $5.41B | $0 | $7.17B | $5.57B | $7.79B | $21M | $2.14B | $0 | $19.94B | |
| Net Debt Issued | $-1.18B | $3.21B | $0 | $-603M | $-1M | $-195M | $-542M | $-154M | $-7.35B | $1.28B | $-5.13B | $18.67B | |
| Stock Issued | $516M | $508M | $284M | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1.03B | $3.23B | $2.14B | $645M | $2.54B | $652M | $1.33B | $2.88B | $2.17B | $3.54B | $2.83B | $1.92B | |
| Net Stock Activity | $-519M | $-3.23B | $-2.14B | $-645M | $-2.54B | $-652M | $-1.33B | $-2.88B | $-2.17B | $-3.54B | $-2.83B | $-1.92B | |
| Dividends Paid | $3.64B | $3.59B | $3.67B | $3.62B | $3.38B | $3.12B | $2.89B | $2.69B | $2.49B | $2.38B | $2.14B | $1.34B | |
| Financing Cash Flow | $-4.75B | $-4.36B | $-4.45B | $-4.96B | $-5.34B | $-4.14B | $-4.20B | $-5.43B | $-11.95B | $-3.28B | $-9.54B | $15.95B | |
| Net Change in Cash | $-269M | $934M | $-259M | $-2.17B | $121M | $-547M | $-253M | $724M | $-1.30B | $2.09B | $-1.97B | $3.44B | |
| Taxes Paid | $1.94B | $1.82B | $1.62B | $1.55B | $996M | $1.25B | $878M | $1.56B | $2.54B | $1.03B | $1.38B | $632M | |
| Free Cash Flow | $5.43B | $5.18B | $5.20B | $4.58B | $5.98B | $4.88B | $6.02B | $5.87B | $3.62B | $5.63B | $4.17B | $4.33B | |
| Levered FCF | · | · | $4.65B | $4.13B | $5.47B | $4.02B | $4.73B | $4.58B | $2.99B | $4.67B | $3.04B | $3.82B |
Lucratividade 8
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 69.8% | 68.7% | 68.3% | 68.9% | |
| Operating Margin | 17.8% | 17.8% | 15.9% | 17.6% | 18.1% | 14.9% | 16.6% | 20.5% | 22.2% | 17.9% | 18.4% | 18.6% | |
| Net Margin | 13.2% | 13.9% | 11.4% | 12.0% | 15.9% | 12.0% | 16.6% | 15.2% | 10.4% | 13.6% | 12.3% | 13.2% | |
| Pretax Margin | 16.9% | 16.8% | 14.9% | 17.2% | 17.4% | 12.9% | 14.0% | 17.0% | 18.9% | 15.5% | 15.0% | 17.2% | |
| EBITDA Margin | 25.9% | 26.3% | 24.1% | 26.2% | 26.7% | 23.9% | 25.8% | 29.2% | 31.0% | 27.8% | 28.1% | 25.0% | |
| ROA | 5.2% | 5.1% | 4.1% | 4.1% | 5.5% | 3.9% | 5.3% | 5.1% | 3.2% | 4.0% | 3.4% | 3.7% | |
| ROE | 9.8% | 9.5% | 7.2% | 7.2% | 9.7% | 7.1% | 9.5% | 9.2% | 6.2% | 7.9% | 6.7% | 7.4% | |
| ROIC | 10.3% | 10.3% | 7.7% | 7.5% | 10.0% | 8.1% | 7.5% | 7.4% | 4.7% | 5.6% | 5.2% | 3.2% |
Liquidez e Solvência 5
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 2.0 | 2.4 | 1.9 | 2.6 | 2.1 | 2.6 | 2.3 | 1.7 | 3.3 | 3.4 | |
| Quick Ratio | 1.4 | 1.2 | 1.3 | 1.5 | 1.3 | 1.9 | 1.5 | 1.9 | 1.7 | 1.4 | 2.5 | 2.7 | |
| Debt / Equity | · | 0.0 | 0.0 | · | · | · | 0.5 | 0.5 | 0.5 | 0.7 | 0.6 | 0.7 | |
| LT Debt / Equity | · | · | · | · | · | · | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | |
| Interest Coverage | · | · | 7.2 | 8.6 | 10.4 | 4.8 | 4.4 | 4.3 | 5.8 | 4.9 | 3.8 | 5.7 |
Eficiência 3
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 2.2 | 2.2 | 2.1 | 2.2 | 2.3 | 2.5 | 2.4 | 2.5 | 2.6 | 2.7 | 2.6 | 2.4 | |
| Receivables Turnover | 5.5 | 5.3 | 5.3 | 5.4 | 5.8 | 6.0 | 5.3 | 5.0 | 5.2 | 5.3 | 5.4 | 4.5 |
Taxas de Crescimento 10
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.4% | 3.6% | 3.6% | -1.5% | 5.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.2% | 1.9% | 2.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 3.3% | 30.8% | -2.1% | -24.4% | 40.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 9.8% | -1.1% | 1.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 7.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3.0% | 26.8% | -2.2% | -25.4% | 39.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 8.5% | -2.6% | 0.64% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 3.1% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 16
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $36.36B | $33.54B | $32.36B | $31.23B | $31.69B | $30.12B | $28.91B | $30.56B | $29.95B | $29.71B | $28.83B | $20.26B | |
| Net Income TTM | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B | $3.61B | $4.79B | $4.63B | $3.10B | $4.03B | $3.54B | $2.67B | |
| Market Cap | $106.66B | $107.89B | $104.57B | $121.04B | $138.88B | $176.14B | $133.17B | $117.11B | $110.08B | $113.79B | $110.73B | $110.33B | |
| Enterprise Value | · | $98.92B | $97.63B | · | · | · | $147.14B | $132.65B | $124.61B | $133.45B | $129.04B | $126.44B | |
| P/E | 22.3 | 23.3 | 28.9 | 32.3 | 28.0 | 49.2 | 28.1 | 25.6 | 35.8 | 28.8 | 31.9 | 32.2 | |
| P/S | 2.9 | 3.2 | 3.2 | 3.9 | 4.4 | 5.8 | 4.6 | 3.8 | 3.7 | 3.8 | 3.8 | 5.4 | |
| P/B | 2.2 | 2.2 | 2.1 | 2.4 | 2.6 | 3.4 | 2.6 | 2.3 | 2.2 | 2.3 | 2.1 | 2.1 | |
| P / Cash Flow | 14.6 | 15.3 | 15.4 | 20.0 | 18.9 | 28.2 | 18.4 | 16.7 | 23.5 | 16.5 | 21.2 | 22.5 | |
| P / FCF | 19.7 | 20.8 | 20.1 | 26.4 | 23.2 | 36.1 | 22.1 | 19.9 | 30.4 | 20.2 | 26.5 | 25.5 | |
| EV / EBITDA | · | 11.2 | 12.5 | · | · | · | 19.7 | 14.9 | 13.4 | 16.2 | 15.9 | 24.9 | |
| EV / FCF | · | 19.1 | 18.8 | · | · | · | 24.4 | 22.6 | 34.5 | 23.7 | 30.9 | 29.2 | |
| EV / Revenue | · | 2.9 | 3.0 | · | · | · | 5.1 | 4.3 | 4.2 | 4.5 | 4.5 | 6.2 | |
| Dividend Yield | 3.4% | 3.3% | 3.5% | 3.0% | 2.4% | 1.8% | 2.2% | 2.3% | 2.3% | 2.1% | 1.9% | 1.2% | |
| Earnings Yield | 4.5% | 4.3% | 3.5% | 3.1% | 3.6% | 2.0% | 3.6% | 3.9% | 2.8% | 3.5% | 3.1% | 3.1% | |
| Payout Ratio | 75.8% | 77.0% | 99.7% | 96.2% | 67.1% | 86.5% | 60.4% | 58.1% | 80.3% | 59.0% | 60.5% | 50.0% | |
| Annual Payout | $3.64B | $3.59B | $3.67B | $3.62B | $3.38B | $3.12B | $2.89B | $2.69B | $2.49B | $2.38B | $2.14B | $1.34B |
Demonstração de Resultados 15
| Métrica | Tendência | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.81B | $9.02B | $8.96B | $8.58B | $8.93B | $8.29B | $8.40B | $7.92B | $8.59B | $8.09B | $7.98B | $7.70B | $8.54B | $7.73B | $7.58B | $7.37B | |
| Cost of Revenue | $3.40B | $3.26B | $3.06B | $3.00B | $3.15B | $2.78B | $2.95B | $2.76B | $3.04B | $2.78B | $2.76B | $2.63B | $2.98B | $2.69B | $2.54B | $2.52B | |
| SG&A Expense | $3.06B | $2.96B | $2.96B | $2.81B | $2.72B | $2.72B | $2.76B | $2.65B | $2.76B | $2.67B | $2.69B | $2.61B | $2.62B | $2.62B | $2.62B | $2.57B | |
| Operating Income | $1.87B | $1.46B | $1.69B | $1.45B | $1.44B | $1.65B | $1.59B | $1.28B | $1.05B | $1.48B | $1.34B | $1.27B | $1.56B | $1.39B | $1.40B | $1.12B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $188M | $180M | $148M | · | $167M | $118M | $164M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $170M | $148M | $111M | · | $118M | $73M | $55M | |
| Other Non-op | $138M | $121M | $92M | $33M | $0 | $72M | $173M | $157M | $5M | $177M | $154M | $76M | $174M | $149M | $109M | $83M | |
| Pretax Income | $1.83B | $1.40B | $1.60B | $1.30B | $1.26B | $1.54B | $1.56B | $1.27B | $856M | $1.47B | $1.31B | $1.20B | $1.55B | $1.38B | $1.40B | $1.04B | |
| Income Tax | $575M | $254M | $215M | $255M | $198M | $237M | $281M | $220M | $196M | $135M | $402M | $400M | $363M | $146M | $959M | $112M | |
| Net Income | $1.24B | $1.14B | $1.37B | $1.04B | $1.06B | $1.29B | $1.27B | $1.04B | $654M | $1.32B | $909M | $791M | $1.18B | $1.22B | $427M | $929M | |
| EPS (Basic) | $0.98 | $0.89 | $1.07 | $0.81 | $0.82 | $1.01 | $0.99 | $0.81 | $0.51 | $0.99 | $0.68 | $0.59 | $0.89 | $0.92 | $0.32 | $0.70 | |
| EPS (Diluted) | $0.96 | $0.89 | $1.07 | $0.81 | $0.81 | $1.01 | $0.99 | $0.80 | $0.50 | $0.99 | $0.68 | $0.59 | $0.88 | $0.92 | $0.32 | $0.70 | |
| Shares (Basic) | -2,564,400,000 | 1,282,600,000 | 1,282,000,000 | 1,281,600,000 | -2,572,500,000 | 1,282,400,000 | 1,282,400,000 | 1,293,300,000 | -2,662,700,000 | 1,329,700,000 | 1,330,200,000 | 1,330,500,000 | -2,659,200,000 | 1,330,200,000 | 1,329,400,000 | 1,329,400,000 | |
| Shares (Diluted) | -2,576,500,000 | 1,289,500,000 | 1,288,000,000 | 1,287,100,000 | -2,579,700,000 | 1,286,200,000 | 1,286,900,000 | 1,296,500,000 | -2,667,200,000 | 1,331,700,000 | 1,331,900,000 | 1,333,800,000 | -2,665,700,000 | 1,332,000,000 | 1,332,000,000 | 1,334,500,000 | |
| EBITDA | · | $1.46B | $1.69B | $2.19B | · | $1.65B | $1.59B | $1.94B | · | $1.48B | $1.34B | $1.94B | · | $1.39B | $1.40B | $1.79B |
Balanço Patrimonial 27
| Métrica | Tendência | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.95B | $1.15B | $1.28B | $1.27B | $2.22B | $1.24B | $1.39B | $1.31B | $1.28B | $1.62B | $1.31B | $1.34B | · | $4.52B | $4.83B | $2.14B | |
| Short-term Investments | $7.27B | $7.24B | $7.04B | $6.85B | $6.75B | $6.68B | $6.59B | $6.53B | $6.72B | $6.70B | $6.42B | $6.54B | · | $6.62B | $6.60B | $6.73B | |
| Receivables | $6.64B | $6.36B | $6.39B | $6.26B | $6.51B | $6.12B | $6.26B | $6.01B | $6.13B | $5.97B | $5.93B | $5.81B | · | $5.89B | $5.63B | $5.31B | |
| Inventory | $5.95B | $6.31B | $6.16B | $5.89B | $5.48B | $5.61B | $5.48B | $5.41B | $5.22B | $5.73B | $5.75B | $5.67B | · | $5.38B | $5.05B | $4.81B | |
| Other Current Assets | $2.97B | $3.02B | $3.12B | $2.95B | $2.86B | $2.87B | $2.71B | $2.68B | $2.58B | $2.50B | $2.66B | $2.52B | · | $2.96B | $3.29B | $3.15B | |
| Current Assets | $24.79B | $24.07B | $24.00B | $23.22B | $23.81B | $22.51B | $22.44B | $21.95B | $21.93B | $22.51B | $22.08B | $21.87B | · | $25.36B | $25.40B | $22.14B | |
| PP&E (Net) | $7.42B | $7.18B | $7.16B | $7.01B | $6.84B | $6.59B | $6.44B | $6.28B | $6.13B | $5.84B | $5.74B | $5.67B | · | $5.44B | $5.30B | $5.28B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $13.93B | $13.50B | $13.32B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $8.49B | $8.20B | $8.04B | |
| Goodwill | $42.59B | $41.89B | $41.81B | $42.01B | $41.74B | $40.82B | $41.16B | $41.08B | $40.99B | $41.16B | $40.82B | $41.44B | $41.42B | $41.56B | $40.42B | $40.32B | |
| Intangibles | $10.15B | $10.34B | $10.77B | $11.22B | $11.67B | $12.18B | $12.42B | $12.82B | $13.22B | $13.69B | $14.06B | $14.43B | · | $15.27B | $15.65B | $15.78B | |
| Other Non-current Assets | $4.15B | $4.04B | $3.75B | $3.58B | $3.58B | $4.25B | $4.01B | $4.06B | $4.05B | $4.04B | $3.96B | $3.91B | · | $3.14B | $3.12B | $3.09B | |
| Total Assets | $93.03B | $91.48B | $91.35B | $90.97B | $91.68B | $89.97B | $90.04B | $89.75B | $89.98B | $90.84B | $90.09B | $90.78B | · | $94.13B | $93.24B | $89.91B | |
| Accounts Payable | $2.64B | $2.57B | $2.58B | $2.56B | $2.45B | $2.29B | $2.38B | $2.29B | $2.41B | $1.99B | $2.17B | $2.24B | · | $2.21B | $2.20B | $2.18B | |
| Short-term Debt | · | · | · | · | $0 | · | · | · | $1.07B | · | · | · | · | · | · | · | |
| Current Liabilities | $11.66B | $9.49B | $9.94B | $11.53B | $12.88B | $11.84B | $12.20B | $10.29B | $10.79B | $9.79B | $9.66B | $9.05B | · | $14.42B | $14.46B | $14.05B | |
| Capital Leases | $989M | · | · | · | $918M | · | · | · | $840M | · | · | · | · | · | · | · | |
| Deferred Tax | $362M | $365M | $386M | $416M | $403M | $452M | $473M | $496M | $515M | $615M | $686M | $687M | · | $747M | $871M | $899M | |
| Other Non-current Liabilities | $2.06B | $1.77B | $1.76B | $1.81B | $1.77B | $1.53B | $1.53B | $1.47B | $1.36B | $1.41B | $1.56B | $1.72B | · | $1.73B | $1.44B | $1.44B | |
| Total Liabilities | $42.96B | $42.29B | $42.49B | $42.84B | $43.42B | $40.36B | $41.33B | $41.59B | $39.56B | $38.84B | $38.44B | $39.41B | · | $42.52B | $41.18B | $37.07B | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | |
| Paid-in Capital | $20.93B | $21.01B | $20.86B | $20.89B | $20.83B | $20.91B | $20.82B | $20.81B | $23.13B | $24.59B | $24.58B | $24.59B | · | $24.51B | $24.44B | $24.34B | |
| Retained Earnings | $32.64B | $32.30B | $32.07B | $31.61B | $31.48B | $31.32B | $30.92B | $30.55B | $30.40B | $30.66B | $30.26B | $30.27B | · | $30.12B | $29.80B | $30.28B | |
| AOCI | $-4.10B | $-4.33B | $-4.28B | $-4.60B | $-4.28B | $-2.84B | $-3.25B | $-3.41B | $-3.32B | $-3.46B | $-3.38B | $-3.67B | · | $-3.19B | $-2.36B | $-1.94B | |
| Stockholders' Equity | $49.46B | $48.98B | $48.65B | $47.89B | $48.02B | $49.39B | $48.49B | $47.95B | $50.21B | $51.79B | $51.46B | $51.18B | · | $51.44B | $51.88B | $52.67B | |
| Liabilities + Equity | $93.03B | $91.48B | $91.35B | $90.97B | $91.68B | $89.97B | $90.04B | $89.75B | $89.98B | $90.84B | $90.09B | $90.78B | · | $94.13B | $93.24B | $89.91B | |
| Shares Outstanding | 1,280,177,293 | 1,283,366,516 | 1,281,984,552 | 1,281,869,213 | 1,281,934,628 | 1,283,266,154 | 1,282,553,150 | 1,282,494,588 | 1,311,000,000 | 1,329,653,024 | 1,330,173,450 | 1,330,498,304 | 1,331,000,000 | 1,330,376,287 | 1,330,148,578 | 1,329,276,973 |
Fluxo de Caixa 18
| Métrica | Tendência | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $716M | $749M | $745M | $748M | $840M | $684M | $675M | $662M | $654M | $649M | $672M | $672M | $679M | $679M | $671M | $668M | |
| Stock-based Comp | $95M | $94M | $182M | $86M | $89M | $98M | $159M | $83M | $90M | $84M | $146M | $73M | $75M | $81M | $137M | $62M | |
| Amort. of Intangibles | $409M | $441M | $463M | $459M | $564M | $416M | $413M | $414M | $420M | $419M | $425M | $429M | $423M | $431M | $421M | $423M | |
| Restructuring | · | $172M | $13M | $67M | · | $46M | $46M | $62M | $300M | $55M | $91M | $91M | $300M | $104M | $95M | $76M | |
| Other Non-cash | · | · | · | $-786M | · | · | · | $-801M | · | · | · | $-661M | · | · | · | $-576M | |
| Operating Cash Flow | $2.57B | $2.74B | $925M | $1.09B | $2.53B | $2.57B | $958M | $986M | $2.78B | $2.47B | $661M | $875M | $2.46B | $1.57B | $922M | $1.08B | |
| CapEx | $488M | $444M | $468M | $504M | $459M | $476M | $404M | $520M | $426M | $346M | $461M | $354M | $378M | $332M | $323M | $426M | |
| Investing Cash Flow | $-917M | $-816M | $-482M | $-719M | $-490M | $-843M | $-345M | $-259M | $-696M | $-707M | $-424M | $-539M | $-475M | $-287M | $-1.15B | $-1.58B | |
| Debt Issued | $0 | $0 | $1.75B | $0 | $0 | $0 | $0 | $3.21B | $0 | $0 | $0 | $0 | $1.98B | $0 | · | · | |
| Net Debt Issued | · | · | · | $-1.16B | · | · | · | $3.21B | · | · | · | $0 | · | · | · | $-2.31B | |
| Stock Repurchased | $435M | $105M | $372M | $123M | $274M | $181M | $288M | $2.49B | $1.63B | $132M | $226M | $152M | $97M | $71M | $141M | $336M | |
| Net Stock Activity | · | · | · | $-123M | · | · | · | $-2.49B | · | · | · | $-152M | · | · | · | $-336M | |
| Dividends Paid | $908M | $911M | $910M | $910M | $897M | $897M | $897M | $898M | $913M | $917M | $918M | $918M | $905M | $904M | $904M | $903M | |
| Financing Cash Flow | $-888M | $-2.09B | $-395M | $-1.38B | $-1.34B | $-1.75B | $-534M | $-731M | $-2.36B | $-1.50B | $-90M | $-501M | $-4.89B | $-2.13B | $3.01B | $-950M | |
| Net Change in Cash | $803M | $-136M | $9M | $-945M | $978M | $-154M | $83M | $27M | $-339M | $312M | $-28M | $-204M | $-2.98B | $-306M | $2.69B | $-1.57B | |
| Taxes Paid | $344M | $204M | $992M | $402M | $304M | $180M | $941M | $394M | $219M | $293M | $993M | $117M | $234M | $493M | $561M | $260M | |
| Free Cash Flow | · | · | · | $584M | · | · | · | $466M | · | · | · | $521M | · | · | · | $657M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $422M | · | · | · | $511M |
Lucratividade 7
| Métrica | Tendência | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 16.2% | 18.8% | 16.9% | · | 19.9% | 19.0% | 16.2% | · | 18.3% | 16.8% | 16.5% | · | 18.0% | 18.5% | 15.3% | |
| Net Margin | · | 12.7% | 15.3% | 12.1% | · | 15.6% | 15.1% | 13.2% | · | 16.3% | 11.4% | 10.3% | · | 15.8% | 5.6% | 12.6% | |
| Pretax Margin | · | 15.6% | 17.8% | 15.2% | · | 18.6% | 18.6% | 16.0% | · | 18.2% | 16.4% | 15.5% | · | 17.8% | 18.4% | 14.2% | |
| EBITDA Margin | · | 16.2% | 18.8% | 25.6% | · | 19.9% | 19.0% | 24.5% | · | 18.3% | 16.8% | 25.2% | · | 18.0% | 18.5% | 24.3% | |
| ROA | · | 1.3% | 1.5% | 1.1% | · | 1.4% | 1.4% | 1.1% | · | 1.4% | 0.99% | 0.88% | · | 1.3% | 0.46% | 1.0% | |
| ROE | · | 2.3% | 2.8% | 2.2% | · | 2.6% | 2.5% | 2.1% | · | 2.6% | 1.8% | 1.5% | · | 2.4% | 0.82% | 1.8% | |
| ROIC | · | 2.5% | 3.0% | 2.4% | · | 2.8% | 2.7% | 2.2% | · | 2.6% | 1.8% | 1.7% | · | 2.4% | 0.85% | 1.9% |
Liquidez e Solvência 3
| Métrica | Tendência | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.5 | 2.4 | 2.0 | · | 1.9 | 1.8 | 2.1 | · | 2.3 | 2.3 | 2.4 | · | 1.8 | 1.8 | 1.6 | |
| Quick Ratio | · | 1.6 | 1.5 | 1.2 | · | 1.2 | 1.2 | 1.3 | · | 1.5 | 1.4 | 1.5 | · | 1.2 | 1.2 | 1.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.9 | 7.4 | 8.6 | · | 8.3 | 11.9 | 6.9 |
Eficiência 3
| Métrica | Tendência | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | |
| Inventory Turnover | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | |
| Receivables Turnover | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 |
Avaliação (TTM) 10
| Métrica | Tendência | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $34.85B | $34.23B | $33.19B | · | $32.70B | $32.39B | $31.69B | · | $31.50B | $31.00B | $30.39B | · | $30.45B | $30.57B | $30.97B | |
| Net Income TTM | · | $4.85B | $4.98B | $4.65B | · | $4.93B | $4.54B | $4.06B | · | $4.24B | $3.35B | $3.37B | · | $4.06B | $4.15B | $4.48B | |
| Market Cap | · | $129.47B | $120.08B | $119.14B | · | $115.74B | $116.19B | $100.93B | · | $115.07B | $92.35B | $117.42B | · | $109.86B | $115.48B | $122.98B | |
| P/E | · | 26.7 | 24.1 | 25.7 | · | 23.8 | 26.2 | 25.7 | · | 27.2 | 27.7 | 34.9 | · | 27.2 | 28.1 | 27.8 | |
| P/S | · | 3.7 | 3.5 | 3.6 | · | 3.5 | 3.6 | 3.2 | · | 3.7 | 3.0 | 3.9 | · | 3.6 | 3.8 | 4.0 | |
| P/B | · | 2.6 | 2.5 | 2.5 | · | 2.3 | 2.4 | 2.1 | · | 2.2 | 1.8 | 2.3 | · | 2.1 | 2.2 | 2.3 | |
| P / Cash Flow | · | · | · | 109.5 | · | · | · | 102.4 | · | · | · | 134.2 | · | · | · | 113.6 | |
| P / FCF | · | · | · | 204.0 | · | · | · | 216.6 | · | · | · | 225.4 | · | · | · | 187.2 | |
| Earnings Yield | · | 3.8% | 4.1% | 3.9% | · | 4.2% | 3.8% | 3.9% | · | 3.7% | 3.6% | 2.9% | · | 3.7% | 3.6% | 3.6% | |
| Payout Ratio | · | · | · | 87.5% | · | · | · | 86.2% | · | · | · | 116.1% | · | · | · | 97.2% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2026-04-24 | 2025-04-25 | 2024-04-26 | 2023-04-28 | 2022-04-29 | |
|---|---|---|---|---|---|
| Receita | $36.36B | $33.54B | $32.36B | $31.23B | $31.69B |
| Margem Operacional % | 17.8% | 17.8% | 15.9% | 17.6% | 18.1% |
| Lucro líquido | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B |
| EPS Diluído | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 |
Balanço Patrimonial
| 2026-04-24 | 2025-04-25 | 2024-04-26 | 2023-04-28 | 2022-04-29 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | — | 0.0 | 0.0 | — | — |
| Índice de liquidez corrente | 2.1 | 1.8 | 2.0 | 2.4 | 1.9 |
| Índice de Liquidez Seca | 1.4 | 1.2 | 1.3 | 1.5 | 1.3 |
Fluxo de Caixa
| 2026-04-24 | 2025-04-25 | 2024-04-26 | 2023-04-28 | 2022-04-29 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $5.43B | $5.18B | $5.20B | $4.58B | $5.98B |
Últimas notícias Notícias recentes mencionando esta empresa
- US jury says Medtronic owes $88 million in first case to go to trial over Covidien's hernia mesh
- Got $2,500? 1 Unstoppable Medical Juggernaut to Buy Hand Over Fist and Hold for the Next 20 Years
- How To Earn $500 A Month From Medtronic Stock After Q4 Earnings
- Relatório Diário de Dividendos: MDT,ACM,UNH,RICK,VRT
- Why Medtronic Stock Popped Today
- 3 Ações de Saúde que Todo Aposentado Deveria Considerar
- Melhor que a Intuitive Surgical? 1 Ação de Saúde Fora do Radar para Comprar e Manter para Sempre
- Medtronic plc (MDT) Recebe a Marcação CE para o Sistema Cirúrgico Stealth AXiS™
- Medtronic diz que ataque cibernético à rede de TI não interrompeu as operações
- Medtronic plc (MDT): Pipeline de Inovação e Mudanças Estruturais Suportam o Caso Otimista
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 2.345 declarantes · $60.8B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 164 (-41 vs trimestre anterior) | 229 (+26 vs trimestre anterior) | 843 (-39 vs trimestre anterior) | 881 (-9 vs trimestre anterior) | +31.2M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $11.142.016.018 | 115.990.173 | 18,32% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.556.983.180 | 83.816.735 | 10,78% | Ações |
| STATE STREET CORP | $5.005.319.950 | 63.399.315 | 8,23% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.664.511.218 | 34.059.967 | 4,38% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $2.023.116.235 | 25.984.601 | 3,33% | Ações |
| NORGES BANK | $1.294.785.982 | 16.551.016 | 2,13% | Ações |
| Capital Research Global Investors | $1.037.443.303 | 13.261.310 | 1,71% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.008.596.703 | 12.892.710 | 1,66% | Ações |
| WCM INVESTMENT MANAGEMENT, LLC | $876.149.302 | 10.826.014 | 1,44% | Ações |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $796.817.845 | 10.185.579 | 1,31% | Ações |
| Capital World Investors | $655.025.579 | 8.373.074 | 1,08% | Ações |
| Dodge & Cox | $616.131.501 | 7.875.898 | 1,01% | Ações |
| AMERIPRISE FINANCIAL INC | $615.938.087 | 7.872.026 | 1,01% | Ações |
| ALLIANCEBERNSTEIN L.P. | $573.774.724 | 6.621.751 | 0,94% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $563.897.017 | 7.208.194 | 0,93% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $494.651.395 | 6.323.038 | 0,81% | Ações |
| Aristotle Capital Management, LLC | $492.360.887 | 6.293.698 | 0,81% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $482.957.188 | 6.173.570 | 0,79% | Ações |
| AMERICAN CENTURY COMPANIES INC | $481.385.824 | 6.153.467 | 0,79% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $466.253.773 | 5.960.038 | 0,77% | Ações |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $452.879.494 | 5.789.077 | 0,74% | Ações |
| BARCLAYS PLC | $426.360.776 | 5.450.093 | 0,70% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $420.775.311 | 5.378.561 | 0,69% | Ações |
| GOLDMAN SACHS GROUP INC | $416.731.067 | 5.326.998 | 0,69% | Ações |
| BlackRock, Inc. | $354.587.488 | 4.532.628 | 0,58% | Ações |
| RAYMOND JAMES FINANCIAL INC | $335.074.029 | 4.283.191 | 0,55% | Ações |
| M&G PLC | $304.332.132 | 3.901.694 | 0,50% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $296.722.791 | 3.792.954 | 0,49% | Ações |
| D. E. Shaw & Co., Inc. | $287.414.282 | 3.673.965 | 0,47% | Ações |
| Swiss National Bank | $283.275.993 | 3.621.066 | 0,47% | Ações |
| JANE STREET GROUP, LLC | $258.949.123 | 3.310.100 | 0,43% | Opção de compra |
| Sumitomo Mitsui Trust Group, Inc. | $257.469.246 | 3.291.183 | 0,42% | Ações |
| TWO SIGMA INVESTMENTS, LP | $253.531.461 | 3.240.847 | 0,42% | Ações |
| Mitsubishi UFJ Asset Management Co., Ltd. | $251.158.901 | 3.210.519 | 0,41% | Ações |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $250.336.000 | 3.200.000 | 0,41% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $247.812.378 | 3.167.741 | 0,41% | Ações |
| National Pension Service | $247.426.235 | 3.162.805 | 0,41% | Ações |
| Legal & General Group Plc | $240.655.505 | 3.076.256 | 0,40% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $226.173.178 | 2.891.131 | 0,37% | Ações |
| Vanguard Global Advisers, LLC | $224.129.498 | 2.865.007 | 0,37% | Ações |
| Qube Research & Technologies Ltd | $216.710.008 | 2.770.165 | 0,36% | Ações |
| LPL Financial LLC | $205.056.905 | 2.621.206 | 0,34% | Ações |
| Cullen Capital Management, LLC | $202.764.187 | 2.591.898 | 0,33% | Ações |
| Burgundy Asset Management Ltd. | $202.732.865 | 2.184.386 | 0,33% | Ações |
| Guinness Asset Management LTD | $201.485.632 | 2.584.951 | 0,33% | Ações |
| USS Investment Management Ltd | $199.360.950 | 2.548.558 | 0,33% | Ações |
| THORNBURG INVESTMENT MANAGEMENT INC | $196.492.638 | 2.511.730 | 0,32% | Ações |
| UBS Group AG | $192.011.702 | 2.454.451 | 0,32% | Ações |
| CITADEL ADVISORS LLC | $190.137.467 | 2.430.493 | 0,31% | Ações |
| NEUBERGER BERMAN GROUP LLC | $190.095.727 | 2.424.452 | 0,31% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $176.664.620 | 2.038.830 | 0,29% | Ações |
| California Public Employees Retirement System | $175.498.444 | 2.243.365 | 0,29% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $173.135.446 | 2.138.003 | 0,28% | Ações |
| RHUMBLINE ADVISERS | $173.126.323 | 2.213.044 | 0,28% | Ações |
| ProShare Advisors LLC | $170.765.687 | 2.182.867 | 0,28% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $169.882.984 | 2.171.583 | 0,28% | Ações |
| Squarepoint Ops LLC | $169.503.679 | 2.166.735 | 0,28% | Ações |
| BANK OF NOVA SCOTIA | $164.717.802 | 2.105.558 | 0,27% | Ações |
| EQUITY INVESTMENT CORP | $161.981.619 | 2.070.582 | 0,27% | Ações |
| Brandywine Global Investment Management, LLC | $152.230.413 | 1.584.743 | 0,25% | Ações |
| BANK OF AMERICA CORP /DE/ | $144.660.491 | 1.849.169 | 0,24% | Ações |
| FMR LLC | $141.159.679 | 1.804.419 | 0,23% | Ações |
| UBS Group AG | $139.937.824 | 1.788.800 | 0,23% | Opção de venda |
| CANADA PENSION PLAN INVESTMENT BOARD | $136.556.176 | 1.745.573 | 0,22% | Ações |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $135.455.714 | 1.731.506 | 0,22% | Ações |
| HSBC HOLDINGS PLC | $134.235.874 | 1.715.913 | 0,22% | Ações |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $131.747.925 | 1.684.110 | 0,22% | Ações |
| 1832 Asset Management L.P. | $131.702.630 | 1.683.531 | 0,22% | Ações |
| FRANKLIN RESOURCES INC | $131.351.612 | 1.679.044 | 0,22% | Ações |
| FEDERATED HERMES, INC. | $129.022.392 | 1.649.270 | 0,21% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $124.465.788 | 1.590.358 | 0,20% | Ações |
| CITADEL ADVISORS LLC | $123.564.285 | 1.579.500 | 0,20% | Opção de venda |
| JANE STREET GROUP, LLC | $122.375.189 | 1.564.300 | 0,20% | Opção de venda |
| PANAGORA ASSET MANAGEMENT INC | $121.070.782 | 1.547.626 | 0,20% | Ações |
| CRAWFORD INVESTMENT COUNSEL INC | $119.126.812 | 1.522.777 | 0,20% | Ações |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $112.773.502 | 1.301.483 | 0,19% | Ações |
| NEW YORK STATE COMMON RETIREMENT FUND | $110.448.713 | 1.411.846 | 0,18% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $100.190.256 | 1.280.714 | 0,16% | Ações |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $99.640.612 | 1.273.688 | 0,16% | Ações |
| Bank of New York Mellon Corp | $97.828.023 | 1.250.518 | 0,16% | Ações |
| MACKENZIE FINANCIAL CORP | $94.730.976 | 1.210.929 | 0,16% | Ações |
| Saratoga Research & Investment Management | $94.132.986 | 1.203.285 | 0,15% | Ações |
| Aberdeen Group plc | $90.825.030 | 1.161.000 | 0,15% | Ações |
| Pictet Asset Management Holding SA | $89.793.686 | 1.147.659 | 0,15% | Ações |
| CIBC Asset Management Inc | $89.727.698 | 1.146.973 | 0,15% | Ações |
| Trexquant Investment LP | $88.614.328 | 1.132.741 | 0,15% | Ações |
| DAVENPORT & Co LLC | $86.729.900 | 1.098.548 | 0,14% | Ações |
| CAPITAL FUND MANAGEMENT S.A. | $86.011.381 | 1.099.468 | 0,14% | Ações |
| AVIVA PLC | $85.897.322 | 1.098.010 | 0,14% | Ações |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $85.550.607 | 1.093.578 | 0,14% | Ações |
| FLOSSBACH VON STORCH SE | $85.222.667 | 1.089.386 | 0,14% | Ações |
| STOREBRAND ASSET MANAGEMENT AS | $83.546.980 | 1.067.966 | 0,14% | Ações |
| Korea Investment CORP | $83.300.869 | 1.064.820 | 0,14% | Ações |
| Baird Financial Group, Inc. | $82.750.131 | 1.057.780 | 0,14% | Ações |
| Bank Julius Baer & Co. Ltd, Zurich | $80.700.169 | 1.024.935 | 0,13% | Ações |
| NOMURA HOLDINGS INC | $78.230.000 | 1.000.000 | 0,13% | Opção de venda |
| Bellevue Group AG | $77.778.848 | 994.233 | 0,13% | Ações |
| Balyasny Asset Management L.P. | $77.109.121 | 985.672 | 0,13% | Ações |
| Susquehanna Portfolio Strategies, LLC | $74.893.021 | 957.344 | 0,12% | Ações |
| TD Asset Management Inc | $73.048.749 | 933.769 | 0,12% | Ações |
Executivos da empresa 42 insiders · 25 diretores · 15 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Geoffrey Martha | Chairman and CEO | 3 de Agosto de 2026 A | 327.866 | 0 | 0 | $0 |
| Thierry Pieton | EVP & Chief Financial Officer | 3 de Agosto de 2026 A | 49.645 | 0 | 0 | $0 |
| Karen L Parkhill | EVP & Chief Financial Officer | 1 de Agosto de 2022 A | 30.962 | 0 | 0 | $0 |
| Kweli Thompson | EVP & President, Neuroscience | 3 de Agosto de 2026 A | 35.390 | 0 | 0 | $0 |
| Denise L. Blomquist | Chief Accounting Officer | 3 de Agosto de 2026 A | 16.998 | 0 | 0 | $0 |
| Matthew R. Walter | SVP, Chief HR Officer | 3 de Agosto de 2026 A | 39.928 | 0 | 1 | $-257.931 |
| Michael Marinaro | EVP, Pres MedSurg and Americas | 3 de Agosto de 2026 A | 117.420 | 0 | 0 | $0 |
| Michelle Quinn | EVP, GC and Secretary | 3 de Agosto de 2026 A | 26.721 | 0 | 0 | $0 |
| Harry Skip Kiil | EVP & President Cardiovascular | 3 de Agosto de 2026 A | 43.669 | 0 | 1 | $-318.623 |
| Gregory L Smith | EVP Global Ops & Supply Chain | 18 de Abril de 2023 F | 28.882 | 0 | 0 | $0 |
| Jennifer M Kirk | Chief Accounting Officer | 1 de Fevereiro de 2023 F | 10.115 | 0 | 0 | $0 |
| Sean Salmon | EVP & President Cardiovascular | 13 de Dezembro de 2022 M | 36.088 | 0 | 0 | $0 |
| Ivan K Fong | EVP GENERAL COUNSEL & SECR | 9 de Dezembro de 2022 F | 32.830 | 0 | 0 | $0 |
| Robert John White | EVP & Pres. Medical Surgical | 7 de Dezembro de 2022 F | 36.186 | 0 | 0 | $0 |
| Brett A. Wall | EVP & Pres Neuroscience | 7 de Dezembro de 2022 F | 25.470 | 0 | 0 | $0 |
| Rob Ten Hoedt | EVP and Pres. Global Regions | 14 de Outubro de 2022 M | 43.483 | 0 | 0 | $0 |
| Carol A Surface | EVP, Chief HR Officer | 1 de Agosto de 2022 A | 26.193 | 0 | 0 | $0 |
| John R Liddicoat | EVP & President of Americas | 29 de Julho de 2022 D | 37.374 | 0 | 0 | $0 |
| Bradley E Lerman | SVP General Counsel & Corp Sec | 5 de Novembro de 2021 F | 48.635 | 0 | 0 | $0 |
| Richard Kuntz | SVP & Chief Medical & Science | 5 de Novembro de 2021 F | 74.945 | 0 | 0 | $0 |
| Michael J Coyle | EVP & Group Pres, Cardiac&Vasc | 3 de Novembro de 2020 F | 190.390 | 0 | 0 | $0 |
| Omar Ishrak | Executive Chairman | 15 de Outubro de 2020 G | 8.650 | 0 | 0 | $0 |
| Hooman Hakami | EVP & Group President Diabetes | 10 de Setembro de 2019 M | 30.761 | 0 | 0 | $0 |
| Bryan C Hanson | EVP, President, MITG | 15 de Dezembro de 2017 S | 88.818 | 0 | 0 | $0 |
| Gary Lee Ellis | EVP & Global Ops and IT | 30 de Dezembro de 2016 G | 180.718 | 0 | 0 | $0 |
| Randall J Hogan | Conselheiro | 28 de Abril de 2026 F | 48.998 | 0 | 0 | $0 |
| Craig Arnold | Conselheiro | 28 de Abril de 2026 F | 42.185 | 0 | 0 | $0 |
| William R Jellison | Conselheiro | 27 de Abril de 2026 A | 6.444 | 0 | 0 | $0 |
| Andrea Jo Goldsmith | Conselheiro | 3 de Maio de 2022 F | 4.450 | 0 | 0 | $0 |
| Elizabeth G Nabel | Conselheiro | 3 de Maio de 2022 F | 11.818 | 0 | 0 | $0 |
| Kevin E Lofton | Conselheiro | 3 de Maio de 2022 F | 2.374 | 0 | 0 | $0 |
| Richard H Anderson | Conselheiro | 3 de Maio de 2022 F | 110.182 | 0 | 0 | $0 |
| Denise M Oleary | Conselheiro | 3 de Maio de 2022 F | 70.917 | 0 | 0 | $0 |
| Michael O Leavitt | Conselheiro | 3 de Maio de 2021 A | 21.779 | 0 | 0 | $0 |
| James T Lenehan | Conselheiro | 3 de Maio de 2021 A | 57.849 | 0 | 0 | $0 |
| Robert C Pozen | Conselheiro | 23 de Agosto de 2018 M | 60.964 | 0 | 0 | $0 |
| Shirley A Jackson | Conselheiro | 1 de Maio de 2018 F | 38.525 | 0 | 0 | $0 |
| Preetha Reddy | Conselheiro | 2 de Maio de 2016 A | 7.823 | 0 | 0 | $0 |
| Medtronic plc | Detentor de 10% | 30 de Janeiro de 2023 P | 4.999.423 | 0 | 0 | $0 |
| Kendall J Powell | — | 28 de Abril de 2026 F | 51.380 | 0 | 0 | $0 |
| Scott C Donnelly | — | 28 de Abril de 2026 F | 23.679 | 0 | 0 | $0 |
| Christopher J Oconnell | — | 19 de Fevereiro de 2015 M | 93.274 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Medtronic plc (2), Covidien Group S.a.r.l. (2) | 21 de Setembro de 2018 | — | Declaração inicial | — | SEC |
| Medtronic plc, Medtronic, Inc., Medtronic International, Ltd. | 16 de Fevereiro de 2016 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 127 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IHI · iShares Trust | 4,64% | 1.731.012 SH | 21 de Agosto de 2026 | Diário |
| CAMX · ADVISORS' INNER CIRCLE FUND | 3,23% | 26.363 NS | 30 de Abril de 2026 | N-PORT |
| AGNG · Global X Funds | 2,60% | 28.814 NS | 31 de Maio de 2026 | N-PORT |
| FLV · AMERICAN CENTURY ETF TRUST | 2,46% | 117.685 NS | 31 de Maio de 2026 | N-PORT |
| ELCV · Strategy Shares | 2,45% | 66.771 NS | 30 de Abril de 2026 | N-PORT |
| ESLV · Strategy Shares | 2,05% | 2.980 NS | 30 de Abril de 2026 | N-PORT |
| IYH · iShares Trust | 1,83% | 765.147 SH | 21 de Agosto de 2026 | Diário |
| HDV · iShares Trust | 1,80% | 3.000.607 SH | 21 de Agosto de 2026 | Diário |
| SPHD · Invesco Exchange-Traded Fund Trust … | 1,80% | 674.601 SH | 21 de Agosto de 2026 | Diário |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,66% | 147.843 SH | 21 de Agosto de 2026 | Diário |
| GEND · Spinnaker ETF Series | 1,60% | 883 NS | 30 de Abril de 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,50% | 25.563 NS | 30 de Abril de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1,48% | 3.859.616 SH | 19 de Agosto de 2026 | Diário |
| IXJ · iShares Trust | 1,43% | 674.832 SH | 21 de Agosto de 2026 | Diário |
| QDIV · Global X Funds | 1,31% | 5.813 NS | 31 de Maio de 2026 | N-PORT |
| SIXH · EXCHANGE TRADED CONCEPTS TRUST | 1,19% | 87.694 NS | 31 de Maio de 2026 | N-PORT |
| SIXA · EXCHANGE TRADED CONCEPTS TRUST | 1,19% | 78.578 NS | 31 de Maio de 2026 | N-PORT |
| SPLV · Invesco Exchange-Traded Fund Trust … | 1,13% | 864.971 SH | 21 de Agosto de 2026 | Diário |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,08% | 329.822 SH | 21 de Agosto de 2026 | Diário |
| CVAR · ETF Opportunities Trust | 1,04% | 4.958 NS | 30 de Abril de 2026 | N-PORT |
| ESUM · Strategy Shares | 0,98% | 18.719 NS | 30 de Abril de 2026 | N-PORT |
| DGRO · iShares Trust | 0,88% | 4.169.807 SH | 21 de Agosto de 2026 | Diário |
| PICB · Invesco Exchange-Traded Fund Trust … | 0,80% | 2.900.000 | 21 de Agosto de 2026 | Diário |
| DIVB · iShares Trust | 0,72% | 150.045 SH | 21 de Agosto de 2026 | Diário |
| LQAI · Exchange Listed Funds Trust | 0,71% | 186 NS | 30 de Abril de 2026 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 0,68% | 31.914 NS | 31 de Maio de 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,53% | 57.783 SH | 19 de Agosto de 2026 | Diário |
| AUSF · Global X Funds | 0,51% | 58.256 NS | 31 de Maio de 2026 | N-PORT |
| CATH · Global X Funds | 0,48% | 72.153 NS | 30 de Abril de 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,47% | 806.965 SH | 19 de Agosto de 2026 | Diário |
| DFUV · Dimensional ETF Trust | 0,45% | 803.592 NS | 30 de Abril de 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,45% | 324.471 NS | 30 de Abril de 2026 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,44% | 7.253.284 SH | 19 de Agosto de 2026 | Diário |
| IWX · iShares Trust | 0,44% | 189.178 SH | 21 de Agosto de 2026 | Diário |
| PFM · Invesco Exchange-Traded Fund Trust | 0,42% | 36.544 SH | 21 de Agosto de 2026 | Diário |
| VYM · VANGUARD WHITEHALL FUNDS | 0,42% | 5.120.062 SH | 19 de Agosto de 2026 | Diário |
| VFMV · VANGUARD WELLINGTON FUND | 0,41% | 21.916 SH | 19 de Agosto de 2026 | Diário |
| IVE · iShares Trust | 0,39% | 2.125.831 SH | 21 de Agosto de 2026 | Diário |
| ESLG · Strategy Shares | 0,39% | 931 NS | 30 de Abril de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,38% | 39.946 SH | 21 de Agosto de 2026 | Diário |
| VTV · VANGUARD INDEX FUNDS | 0,38% | 12.209.067 SH | 19 de Agosto de 2026 | Diário |
| IUSV · iShares Trust | 0,37% | 1.115.419 SH | 21 de Agosto de 2026 | Diário |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,35% | 295.656 SH | 19 de Agosto de 2026 | Diário |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,35% | 430.000 | 21 de Agosto de 2026 | Diário |
| ILCV · iShares Trust | 0,34% | 49.823 SH | 21 de Agosto de 2026 | Diário |
| IWD · iShares Trust | 0,32% | 2.847.266 SH | 21 de Agosto de 2026 | Diário |
| DYNF · BlackRock ETF Trust | 0,31% | 1.372.122 SH | 21 de Agosto de 2026 | Diário |
| CHRI · Global X Funds | 0,31% | 196 NS | 30 de Abril de 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,28% | 774.434 SH | 19 de Agosto de 2026 | Diário |
| EGLE · Global X Funds | 0,26% | 65 NS | 30 de Abril de 2026 | N-PORT |